Consistent with our findings, Beird et al. demonstrated that the plasmacytoid dendritic cell markers CCDC50 and LAMP5 were significantly more highly expressed in BPDCN than in AML, as revealed by transcriptome microarray analysis [30]. This evidence concerns the gene LAMP5 and acute myeloid leukemia.